Provided by Tiger Trade Technology Pte. Ltd.

Relay Therapeutics

8.50
+0.910011.99%
Post-market: 8.570.0700+0.82%18:37 EST
Volume:2.43M
Turnover:20.32M
Market Cap:1.47B
PE:-4.86
High:8.64
Open:7.57
Low:7.42
Close:7.59
52wk High:9.04
52wk Low:1.78
Shares:173.32M
Float Shares:102.63M
Volume Ratio:0.79
T/O Rate:2.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7494
EPS(LYR):-2.3638
ROE:-41.14%
ROA:-25.37%
PB:2.42
PE(LYR):-3.60

Loading ...

Relay Therapeutics Files Initial Beneficial Ownership Statement for Director Habib J. Dable

Reuters
·
Nov 07, 2025

Relay Therapeutics Q3 EPS $(0.43) Misses $(0.42) Estimate

Benzinga
·
Nov 07, 2025

Relay Therapeutics Q3 Net Income USD -74.149 Million Vs. IBES Estimate USD -73.9 Million

Reuters
·
Nov 07, 2025

Relay Therapeutics Q3 Operating Expenses USD 80.391 Million

THOMSON REUTERS
·
Nov 07, 2025

Top Executive Makes Significant Stock Sale at Relay Therapeutics

TIPRANKS
·
Nov 05, 2025

Top Executives at Relay Therapeutics Cash In on Major Stock Sales!

TIPRANKS
·
Oct 31, 2025

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025

GlobeNewswire
·
Oct 31, 2025

Barfresh Food Group Among 3 Promising Penny Stocks

Simply Wall St.
·
Sep 19, 2025

Relay Therapeutics Coverage Assumed by Guggenheim at Buy

Dow Jones
·
Sep 04, 2025

Relay Therapeutics Inc. to Participate in Wells Fargo Healthcare and Morgan Stanley Global Conferences

Reuters
·
Aug 29, 2025

HC Wainwright Adjusts Price Target on Relay Therapeutics to $14 From $16, Maintains Buy Rating

MT Newswires Live
·
Aug 26, 2025

Relay Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 26, 2025

Relay Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $14 From $16

THOMSON REUTERS
·
Aug 26, 2025

Stock Track | Relay Therapeutics Plummets 8.60% Despite Beating Q2 Estimates as Raymond James Slashes Target Price

Stock Track
·
Aug 08, 2025

Relay Therapeutics Q2 EPS $(0.41) Beats $(0.48) Estimate, Sales $677.000K Beat $54.545K Estimate

Benzinga
·
Aug 08, 2025

Relay Therapeutics Q2 Operating Income USD -76.847 Million

THOMSON REUTERS
·
Aug 08, 2025

Relay Therapeutics Q2 Revenue USD 677 Thousand

THOMSON REUTERS
·
Aug 08, 2025

Relay Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
Aug 06, 2025

Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025

GlobeNewswire
·
Aug 01, 2025

Peter Rahmer, Officer, Reports Disposal of Common Shares of Relay Therapeutics Inc

Reuters
·
Jul 31, 2025